Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifford J Bailey

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|April 15, 2011
The challenge of managing coexistent type 2 diabetes and obesityClifford J Bailey
Diabetes & Vascular Disease Research|December 13, 2006
Early and intensive treatment: Glycaemic control in type 2 diabetesClifford J Bailey
Diabetes & Vascular Disease Research|May 1, 2007
Treating insulin resistance: future prospectsClifford J Bailey
Diabetes & Vascular Disease Research|November 25, 2005
Whence and whither the fixed-dose combination?Clifford J Bailey
Diabetologia|November 1, 2025
Pharmacological therapies for type 2 diabetes: future approachesClifford J Bailey
The Lancet. Diabetes & Endocrinology|July 6, 2023
Prediabetes: never too early to interveneClifford J Bailey
Therapeutic Advances in Endocrinology and Metabolism|August 12, 2024
Diabetes and gout: another role for SGLT2 inhibitors?Clifford J Bailey
Diabetes, Obesity & Metabolism|May 24, 2024
Metformin: Therapeutic profile in the treatment of type 2 diabetesClifford J Bailey
Nature Reviews. Endocrinology|July 24, 2019
Treating T2DM and obesity with bariatric surgery and GLP1 agentsClifford J Bailey
Diabetes, Obesity & Metabolism|February 15, 2019
FDA guidance on cardiovascular risk of antidiabetic therapies: One decade laterClifford J Bailey
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|April 15, 2011
The challenge of managing coexistent type 2 diabetes and obesityClifford J Bailey
Diabetes & Vascular Disease Research|December 13, 2006
Early and intensive treatment: Glycaemic control in type 2 diabetesClifford J Bailey
Diabetes & Vascular Disease Research|May 1, 2007
Treating insulin resistance: future prospectsClifford J Bailey
Diabetes & Vascular Disease Research|November 25, 2005
Whence and whither the fixed-dose combination?Clifford J Bailey
Diabetologia|November 1, 2025
Pharmacological therapies for type 2 diabetes: future approachesClifford J Bailey
The Lancet. Diabetes & Endocrinology|July 6, 2023
Prediabetes: never too early to interveneClifford J Bailey
Therapeutic Advances in Endocrinology and Metabolism|August 12, 2024
Diabetes and gout: another role for SGLT2 inhibitors?Clifford J Bailey
Diabetes, Obesity & Metabolism|May 24, 2024
Metformin: Therapeutic profile in the treatment of type 2 diabetesClifford J Bailey
Nature Reviews. Endocrinology|July 24, 2019
Treating T2DM and obesity with bariatric surgery and GLP1 agentsClifford J Bailey
Diabetes, Obesity & Metabolism|February 15, 2019
FDA guidance on cardiovascular risk of antidiabetic therapies: One decade laterClifford J Bailey
Pageof 12